CYP2D6 and Parkinson disease: Surprisingly, their contribution to the risk of developing PD has barely been studied so far (Breckenridge et al., 2016) although besides CYP2D6 15 more P450s are involved in the biotransformation of drugs and xenobiotics so that it is challenging to investigate their potential as a risk factor for PD.